Gene · 11255
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and neural mechanisms of sleep disorders in children with autism spectrum disorder: a review. | Front Psychiatry | 2023 | 37200906 | PubTator, text mining | PubMed |
| Synthesis of sulfur-containing benzo[b]pyrrolo[2,1-c][1,4]oxazine-3,9-diones: blue light promoted radical cyclization process. | RSC Adv | 2023 | 37197573 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Bronchial Asthma Specific to the Population of the Russian Federation. | Acta Naturae | 2023 | 37153512 | PubTator, text mining | PubMed |
| G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. | Signal Transduct Target Ther | 2023 | 37137892 | PubTator, text mining | PubMed |
| Histaminergic neurotransmission in aging and Alzheimer's disease: A review of therapeutic opportunities and gaps. | Alzheimers Dement (N Y) | 2023 | 37123051 | PubTator, text mining | PubMed |
| Role of Histamine and Related Signaling in Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis. | Viruses | 2023 | 37112991 | PubTator, text mining | PubMed |
| Naturally Occurring Chalcones with Aggregation-Induced Emission Enhancement Characteristics. | Molecules | 2023 | 37110646 | PubTator, text mining | PubMed |
| Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones. | Molecules | 2023 | 37110645 | PubTator, text mining | PubMed |
| Evaluation of Some Safety Parameters of Dual Histamine H3 and Sigma-2 Receptor Ligands with Anti-Obesity Potential. | Int J Mol Sci | 2023 | 37108661 | PubTator, text mining | PubMed |
| Ameliorating parkinsonian motor dysfunction by targeting histamine receptors in entopeduncular nucleus-thalamus circuitry. | Proc Natl Acad Sci U S A | 2023 | 37068253 | PubTator, text mining | PubMed |
| LINC01589 serves as a potential tumor-suppressor and immune-related biomarker in endometrial cancer: A review. | Medicine (Baltimore) | 2023 | 37058060 | PubTator, text mining | PubMed |
| Editorial: Experimental and innovative approaches to multi-target treatment of Parkinson's and Alzheimer's diseases - Volume II. | Front Neurosci | 2023 | 37034172 | PubTator, text mining | PubMed |
| Transitions between cognitive topographies: contributions of network structure, neuromodulation, and disease. | bioRxiv | 2023 | 36993597 | PubTator, text mining | PubMed |
| Orphan Drugs in Neurology-A Narrative Review. | J Pers Med | 2023 | 36983602 | PubTator, text mining | PubMed |
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia. | Int J Mol Sci | 2023 | 36983018 | PubTator, text mining | PubMed |
| Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial. | Lancet Neurol | 2023 | 36931805 | PubTator, text mining | PubMed |
| Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. | J Pharmacol Sci | 2023 | 36925216 | PubTator, text mining | PubMed |
| Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives. | Molecules | 2023 | 36903593 | PubTator, text mining | PubMed |
| Histaminergic System and Inflammation-Related Genes in Normal Large Intestine and Adenocarcinoma Tissues: Transcriptional Profiles and Relations. | Int J Mol Sci | 2023 | 36902343 | PubTator, text mining | PubMed |
| Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy. | Cells | 2023 | 36899876 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11255/papers?page=9